
Beximco Pharmaceuticals Investor Relations Material
Latest events

H1 24/25
28 Jan, 2025

Q1 24/25
15 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Beximco Pharmaceuticals PLC
Access all reports
Beximco Pharmaceuticals Limited, also known as Beximco Pharma, is a prominent pharmaceutical company based in Bangladesh, part of the Bangladesh Export Import Company Limited (BEXIMCO). Established in 1980, Beximco Pharma has grown to manufacture and market its own branded generics for various diseases including AIDS, cancer, asthma, hypertension, and diabetes, catering to both national and international markets. It holds the distinction of being the first drug company from Bangladesh to sell its products in the US market. The company operates out of its headquarters in Dhanmondi, Dhaka, Bangladesh, and its shares are listed on the Dhaka Stock Exchange and the London Stock Exchange.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
BXP
Country
🇬🇧 United Kingdom